Latest news
Sonoma Pharmaceuticals Q1 revenue rises on US growth - TradingViewTradingView · Thu, 06 Aug 2026 13:07:34 GMTSonoma Pharmaceuticals Delivers 141% U.S. Revenue Growth in FY Q1, 60% Total Revenue Growth and First-Ever Positive Adjusted EBITDA - Bay to Bay NewsBay to Bay News · Thu, 06 Aug 2026 13:02:40 GMTSonoma U.S. Revenue Climbs 141%; First-Ever Positive Adjusted EBITDA - Stock TitanStock Titan · Thu, 06 Aug 2026 13:00:00 GMTSonoma Pharmaceuticals, Inc. Q1 2027: Revenue $6.41M, EPS $(0.09) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 12:41:00 GMTSonoma Pharmaceuticals Turns EBITDA Positive for First Time with Record Quarterly Revenue - TradingViewTradingView · Thu, 06 Aug 2026 12:33:39 GMTSonoma Pharmaceuticals (SNOA) Slides 5.83% to $1.13 as Key Support Level Looms - ATR Trailing Stop - dars.gov.etdars.gov.et · Thu, 06 Aug 2026 02:35:24 GMTSonoma Pharmaceuticals (Nasdaq: SNOA) 2026 pay, board and auditor votes - Stock TitanStock Titan · Tue, 28 Jul 2026 20:50:46 GMTSonoma Pharmaceuticals Inc - TradingKeyTradingKey · Mon, 27 Jul 2026 12:31:36 GMT